Intrexon | XON - Current Assets

Intrexon reported $118.16M in Current Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
Amgen AMGN:US USD 22.19B 1.88B
Anika Therapeutics ANIK:US USD 169.55M 1.79M
Arrowhead Research ARWR:US USD 575M 169.7M
AstraZeneca AZN:LN USD 22.59B 2.37B
Bluebird Bio BLUE:US USD 160.44M 7.02M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Immunogen IMGN:US USD 304.12M 26.3M
Intrexon XON:US USD 118.16M 44.65M
Karyopharm Therapeutics KPTI:US USD 356.48M 133.8M
Ligand Pharmaceuticals LGND:US USD 263.6M 43.17M
Macrogenics MGNX:US USD 222.18M 74.37M
Mannkind MNKD:US USD 234.9M 16.52M
Novartis NOVN:VX USD 36.91B 44M
Peregrine Pharmaceuticals PPHM:US USD 132.34M 13.6M
Rigel Pharmaceuticals RIGL:US USD 115.9M 5.46M
Roche Holding ROG:VX 33.82B 3.5B
Sangamo Biosciences SGMO:US USD 300.33M 36.29M
Thermo Fisher Scientific TMO:US USD 25.36B 6.07B
Veracyte VCYT:US USD 248.64M 10.12M
Xencor XNCR:US USD 675.34M 7.34M
YTE INCY:US USD 4.09B 271.74M
Ziopharm Oncology ZIOP:US USD 53.8M 1.71M